4 Midcap One-Year Return 30-60 Per Cent Stocks to Watch for Future Multibagger Potential: Federal Bank, Radico Khaitan, NALCO and Ajanta Pharma
- October 28, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Federal Bank Rs 341.60. Radico Khaitan Rs 4,290. NALCO Rs 308.20. Ajanta Pharma Rs 3,353.60. Market caps from Rs 42,214 crore to Rs 81,847 crore. Data as of 27 Oct 2026.
Quick Answer
Federal Bank, Radico Khaitan, NALCO and Ajanta Pharma are the 4 picks in this one-year return 30-60 per cent stocks watchlist, with market caps between Rs 42,214 crore and Rs 81,847 crore. Federal Bank stands out for the largest market cap at Rs 81,847 crore, while Radico Khaitan offers the fastest profit growth, 24.88% a year since FY22. PE ratios run from 8.63 to 85.71, so compare each one with its industry PE before investing. All figures are as of 27 October 2026.
One-year return 30-60 per cent stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Federal Bank, Radico Khaitan, NALCO and Ajanta Pharma meet that test, with market caps from Rs 42,214 crore to Rs 81,847 crore and Federal Bank offering the largest market cap at Rs 81,847 crore. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a one-year share price return between 30 and 60 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a one-year share price return between 30 and 60 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening one-year return 30-60 per cent stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 27 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are One-Year Return 30-60 Per Cent Stocks and Why Do They Attract Multibagger Interest?
One-year return 30-60 per cent stocks are shares that rose 30 to 60 per cent over the past year, a strong run that shows the market is rewarding the business for its progress. The four here cover private banking, spirits, aluminium and pharmaceuticals.
A strong yearly gain that comes with rising profit shows that the rally rests on business results and not on talk alone. For one-year return 30-60 per cent stocks, both FY26 and the latest quarter showed growth. Whichever way you read one-year return 30-60 per cent stocks, the common thread is rising profit backed by complete financial data. For one-year return 30-60 per cent stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of one-year return 30-60 per cent stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for one-year return 30-60 per cent stocks before you decide.
One-Year Return 30-60 Per Cent Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book
Prices are closing prices as of 27 October 2026. NALCO combines the lowest PE of the group, 8.63, with the highest return on equity, 26.83%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Price to Book | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Federal Bank | 341.60 | 81,847 | 15.19 | 11.94 | 12.60% | 1.98 | 211.52 to 371.70 |
| Radico Khaitan | 4,290 | 60,304 | 85.71 | 54.95 | 18.23% | 18.19 | 2,500.00 to 4,747.00 |
| National Aluminium Company | 308.20 | 58,218 | 8.63 | 12.46 | 26.83% | 2.70 | 222.71 to 445.15 |
| Ajanta Pharma | 3,353.60 | 42,214 | 37.20 | 36.35 | 23.33% | 9.32 | 2,380.20 to 3,796.00 |
Federal Bank: 22.90% Profit CAGR Since FY22
Federal Bank is a Kerala-based private sector bank with a strong NRI deposit base and a growing retail, small business and digital franchise. It reported FY26 total income of Rs 34,272.42 crore, up 7.00% year on year, and net profit of Rs 4,483.38 crore, up 6.71%. Net profit has compounded at 22.90% a year since FY22, while total income has grown 20.05% a year.
In the September 2026 quarter, total income rose 19.01% to Rs 9,903.41 crore and net profit grew 53.42% to Rs 1,564.06 crore. The share price has gained 259.57% over five years and 57.58% over the past year. Domestic institutions raised their holding from 48.17% in June 2025 to 49.28% in June 2026. The stock trades at a PE of 15.19 against an industry PE of 11.94, with a return on equity of 12.60%.
Radico Khaitan: 24.88% Profit CAGR Since FY22
Radico Khaitan makes Indian-made foreign liquor and premium spirits, with brands including Magic Moments, 8PM and Rampur Single Malt. It reported FY26 revenue of Rs 6,062.27 crore, up 24.84% year on year, and net profit of Rs 604.48 crore, up 74.90%. Net profit has compounded at 24.88% a year since FY22, while revenue has grown 20.50% a year. Operating margin was 4.88% in FY26. The debt-to-equity ratio is 0.15, which keeps interest costs low.
The stock trades at a PE of 85.71 against an industry PE of 54.95, with a return on equity of 18.23%. In the June 2026 quarter, revenue rose 10.44% to Rs 5,869.46 crore and net profit grew 75.91% to Rs 229.60 crore. The share price has gained 299.58% over five years and 51.47% over the past year. Domestic institutions raised their holding from 25.47% in September 2025 to 27.17% in September 2026.
NALCO: Return on Equity of 26.83%
National Aluminium Company is a government-owned, integrated bauxite-to-aluminium producer with operations in Odisha. It reported FY26 revenue of Rs 18,508.88 crore, up 7.96% year on year, and net profit of Rs 5,797.01 crore, up 10.04%. Net profit has compounded at 18.38% a year since FY22, while revenue has grown 6.33% a year. Operating margin was 48.16% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.
In the June 2026 quarter, revenue rose 39.31% to Rs 5,475.68 crore and net profit grew 90.87% to Rs 2,003.14 crore. The share price has gained 160.35% over five years and 39.86% over the past year. Foreign investors raised their holding from 15.06% in June 2025 to 21.99% in June 2026. The stock trades at a PE of 8.63 against an industry PE of 12.46, below the sector average, with a return on equity of 26.83%. The dividend yield is 3.63%.
Ajanta Pharma: Return on Equity of 23.33%
Ajanta Pharma sells branded generics in ophthalmology, dermatology, cardiology and pain management in India, Africa and Asia. It reported FY26 revenue of Rs 5,624.93 crore, up 18.60% year on year, and net profit of Rs 1,056 crore, up 14.73%. Net profit has compounded at 10.33% a year since FY22, while revenue has grown 12.94% a year. Operating margin was 28.74% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.
The stock trades at a PE of 37.20 against an industry PE of 36.35, with a return on equity of 23.33%. In the June 2026 quarter, revenue rose 27.68% to Rs 1,696.86 crore and net profit grew 30.89% to Rs 334.22 crore. The share price has gained 125.31% over five years and 35.42% over the past year. Domestic institutions raised their holding from 17.90% in September 2025 to 21.94% in September 2026.
One-Year Return 30-60 Per Cent Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these one-year return 30-60 per cent stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Total Income (Rs Cr) | Net Profit (Rs Cr) | Income Growth (YoY) | 4-Year Income CAGR | 4-Year Net Profit CAGR |
|---|---|---|---|---|---|
| Federal Bank | 34,272.42 | 4,483.38 | 7.00% | 20.05% | 22.90% |
| Radico Khaitan | 6,062.27 | 604.48 | 24.84% | 20.50% | 24.88% |
| NALCO | 18,508.88 | 5,797.01 | 7.96% | 6.33% | 18.38% |
| Ajanta Pharma | 5,624.93 | 1,056 | 18.60% | 12.94% | 10.33% |
Check the Univest Screener for live data on these one-year return 30-60 per cent stocks
Institutional Holding in Federal Bank, Radico Khaitan, NALCO and Ajanta Pharma
Institutional holding shows who is backing these one-year return 30-60 per cent stocks alongside the promoter. The table uses the latest reported quarter for each. Federal Bank has the deepest institutional backing, with FII and DII together holding 76.99% as of June 2026. Domestic institutions increased their holding over the past year in Federal Bank (from 48.17% to 49.28%), Radico Khaitan (from 25.47% to 27.17%) and Ajanta Pharma (from 17.90% to 21.94%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Federal Bank | Nil | 27.71% | 49.28% | 23.01% | June 2026 |
| Radico Khaitan | 40.17% | 19.43% | 27.17% | 13.23% | September 2026 |
| NALCO | 51.28% | 21.99% | 11.22% | 15.51% | June 2026 |
| Ajanta Pharma | 63.47% | 7.63% | 21.94% | 6.96% | September 2026 |
Risks to Weigh in One-Year Return 30-60 Per Cent Stocks
Being careful with one-year return 30-60 per cent stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Radico Khaitan trades at a PE of 85.71 against an industry PE of 54.95, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between One-Year Return 30-60 Per Cent Stocks
Picking from one-year return 30-60 per cent stocks comes down to four checks, applied in order.
- Check asset quality and net interest margin first, then return on equity and Price to Book. Debt-to-equity does not apply to lenders.
- Compare each PE with the industry PE (11.94 to 54.95) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Federal Bank, Radico Khaitan, NALCO and Ajanta Pharma live prices.
Conclusion
Among one-year return 30-60 per cent stocks, Federal Bank stands out for the largest market cap at Rs 81,847 crore, Radico Khaitan for the fastest profit growth, 24.88% a year since FY22, NALCO for the highest return on equity at 26.83% and Ajanta Pharma for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing one-year return 30-60 per cent stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on One-Year Return 30-60 Per Cent Stocks to Watch
Which are the best one-year return 30-60 per cent stocks to watch for multibagger potential?
Ans. Federal Bank, Radico Khaitan, NALCO and Ajanta Pharma are the 4 names this list highlights, with market caps of Rs 81,847 crore, Rs 60,304 crore, Rs 58,218 crore and Rs 42,214 crore respectively. Federal Bank is notable for the largest market cap at Rs 81,847 crore. Radico Khaitan stands out for the fastest profit growth, 24.88% a year since FY22. NALCO offers the highest return on equity at 26.83%. Ajanta Pharma brings a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06. These are watchlist names for one-year return 30-60 per cent stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is NALCO a good stock for long-term investors?
Ans. NALCO has a return on equity of 26.83%, a PE of 8.63 against an industry PE of 12.46 and a market cap of Rs 58,218 crore. Net profit has compounded at 18.38% a year since FY22, and FY26 revenue rose 7.96% while June 2026 quarter net profit grew 90.87%. Long-term returns in one-year return 30-60 per cent stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Radico Khaitan become a multibagger from here?
Ans. Radico Khaitan has already gained 299.58% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in one-year return 30-60 per cent stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 24.88% a year since FY22, and FY26 revenue rose 24.84%. At a PE of 85.71 against an industry PE of 54.95, valuation should be checked against that growth before investing.
What is the market cap of Federal Bank, Radico Khaitan, NALCO and Ajanta Pharma?
Ans. As of 27 October 2026, Federal Bank has a market cap of Rs 81,847 crore, Radico Khaitan has a market cap of Rs 60,304 crore, NALCO has a market cap of Rs 58,218 crore and Ajanta Pharma has a market cap of Rs 42,214 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on one-year return 30-60 per cent stocks.
What are the risks of investing in one-year return 30-60 per cent stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Radico Khaitan trades at a PE of 85.71 against an industry PE of 54.95, so earnings growth needs to hold up.
Why is Radico Khaitan trading at a PE of 85.71?
Ans. Radico Khaitan’s PE of 85.71 compares with an industry PE of 54.95. The market is paying a premium for a return on equity of 18.23%, profit growth of 24.88% a year since FY22 and latest-quarter profit growth of 75.91%, which also means the stock is more sensitive if growth slows. Investors in one-year return 30-60 per cent stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Federal Bank, Radico Khaitan, NALCO and Ajanta Pharma?
Ans. As of the latest reported quarter, FII and DII together hold 76.99% of Federal Bank (27.71% and 49.28%), 46.60% of Radico Khaitan (19.43% and 27.17%), 33.21% of NALCO (21.99% and 11.22%) and 29.57% of Ajanta Pharma (7.63% and 21.94%). Rising institutional holding is a useful signal in one-year return 30-60 per cent stocks, though it should be read with earnings trends rather than on its own.
